大学院生 木原祐希 先生（小児科）の論文です。
“In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death”
KIHARA Yuki†, TANAKA Yukie, IKEDA Masanari, HOMMA Jun, TAKAGI Ryo, ISHIGAKI Keiko, YAMANOUCHI Keitaro, HONDA Hiroaki, NAGATA Satoru, YAMATO Masayuki*
Regenerative Therapy, 21, 486-493(2022)
doi：10.1016/j.reth.2022.10.003
Abstract
Introduction: Duchenne muscular dystrophy (DMD) is a progressive disease that leads to damage of muscle and myocardium due to genetic abnormalities in the dystrophin gene. In utero cell transplantation that might facilitate allogenic transplantation is worth considering to treat this disease.
Methods: We performed allogeneic in utero transplantation of GFP-positive myoblasts and adipose-derived mesenchymal stem cells into murine DMD model animals. The transplantation route in this study was fetal intraperitoneal transplantation and transplacental transplantation. Transplanted animals were examined at 4-weeks old by immunofluorescence staining and RT-qPCR.
Results: No GFP-positive cells were found by immunofluorescence staining of skeletal muscle and no GFP mRNA was detected by RT-qPCR in any animal, transplantation method and cell type. Compared with previous reports, myoblast transplantation exhibited an equivalent mortality rate, but adipose-derived stem cell (ASC) transplantation produced a higher mortality rate.
Conclusions: In utero transplantation of myoblasts or ASCs to murine models of DMD does not lead to engraftment and, in ASC transplantation primarily, frequently results in fetal death.
Keywords: Adipose-derived mesenchymal stem cells; Duchenne muscular dystrophy; Fetal therapy; In utero transplantation; Myoblasts.
